GB1500043A - Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion - Google Patents

Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion

Info

Publication number
GB1500043A
GB1500043A GB6869/75A GB686975A GB1500043A GB 1500043 A GB1500043 A GB 1500043A GB 6869/75 A GB6869/75 A GB 6869/75A GB 686975 A GB686975 A GB 686975A GB 1500043 A GB1500043 A GB 1500043A
Authority
GB
United Kingdom
Prior art keywords
acid secretion
gastric acid
formula
preparation
benzimidazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB6869/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of GB1500043A publication Critical patent/GB1500043A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
GB6869/75A 1974-02-18 1975-02-18 Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion Expired GB1500043A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7402101A SE418966B (sv) 1974-02-18 1974-02-18 Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan

Publications (1)

Publication Number Publication Date
GB1500043A true GB1500043A (en) 1978-02-08

Family

ID=20320233

Family Applications (1)

Application Number Title Priority Date Filing Date
GB6869/75A Expired GB1500043A (en) 1974-02-18 1975-02-18 Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion

Country Status (23)

Country Link
JP (1) JPS5924157B2 (en:Method)
AT (1) AT343659B (en:Method)
AU (1) AU499639B2 (en:Method)
BE (1) BE825655A (en:Method)
CA (1) CA1060448A (en:Method)
CH (1) CH616160A5 (en:Method)
CS (1) CS194715B2 (en:Method)
DD (1) DD119422A5 (en:Method)
DE (1) DE2504252A1 (en:Method)
DK (1) DK141122B (en:Method)
FI (1) FI59590C (en:Method)
FR (1) FR2261007B1 (en:Method)
GB (1) GB1500043A (en:Method)
HK (1) HK67080A (en:Method)
HU (1) HU172141B (en:Method)
IE (1) IE40858B1 (en:Method)
LU (1) LU71872A1 (en:Method)
MY (1) MY8100208A (en:Method)
NL (1) NL7501917A (en:Method)
NO (1) NO142401C (en:Method)
SE (1) SE418966B (en:Method)
SU (1) SU795476A3 (en:Method)
ZA (1) ZA75558B (en:Method)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182766A (en) * 1977-09-19 1980-01-08 Hoffmann-La Roche Inc. Naphth[2,3-d]imidazoles
GB2134523A (en) * 1983-02-11 1984-08-15 Haessle Ab Novel pharmacologically active compounds
US4746667A (en) * 1981-08-13 1988-05-24 Aktiebolaget Hassle Pharmaceutical composition containing 2-(2-benzimidazolyl thiomethyl) pyridine
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5008278A (en) * 1988-12-22 1991-04-16 Aktiebolaget Hassle Therapeutically active compound and a process for its preparation
EP0150586B1 (en) * 1983-12-05 1991-05-08 The Upjohn Company 2-(pyridylmethylthio)benzimidazoles and 2-(pyridylmethylsulfinyl)benzimidazoles
US5025024A (en) * 1988-12-22 1991-06-18 Aktiebolaget Hassle Therapeutically active fluoro-substituted compound
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
EP0233284B1 (en) * 1985-10-29 1992-08-19 Aktiebolaget Hässle Pharmacological compounds
EP0510719A1 (en) 1986-11-21 1992-10-28 Aktiebolaget Hässle Benzimidazole derivatives substituted with a radical group and their use for inhibiting gastric acid secretion
US5175286A (en) * 1988-09-20 1992-12-29 Hisamitsu Pharmaceutical Co., Inc. Dibenz[b,e]oxepin derivatives
US5441968A (en) * 1989-12-20 1995-08-15 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
LT3810B (en) 1986-11-21 1996-03-25 Haessle Ab New benzimidazole derivatives, a process for production thereof and a pharmaceuticalcomposition containing the same
LT3952B (en) 1990-06-20 1996-05-27 Astra Ab Substituted benzimidazoles, process for their preparation and their pharmaceutical use
LT3981B (en) 1988-12-22 1996-06-25 Haessle Ab Therapeutically active substituted benzimidazole and process for its preparation

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
JPS5364103A (en) * 1976-09-24 1978-06-08 Hitachi Ltd Waste heat recovery boiler
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
AT373888B (de) * 1979-01-10 1984-02-27 Janssen Pharmaceutica Nv Verfahren zur herstellung von neuen 4-piperidinaminen und deren saeureadditionssalzen
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
DE3047388A1 (de) * 1980-12-16 1982-07-15 Basf Ag, 6700 Ludwigshafen Isatogenderivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US4503139A (en) * 1983-05-09 1985-03-05 Polaroid Corporation Photographic products and processes and novel compounds
US4767770A (en) * 1984-06-18 1988-08-30 Eli Lilly And Company Method of inhibiting aromatase
FR2593178B1 (fr) * 1986-01-20 1988-04-29 Esteve Labor Dr Derives de 2-benzimidazolylalkylthio (ou sulfinyle ou sulfonyle) leur preparation et leur application en tant que medicaments.
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
JPH021280U (en:Method) * 1988-06-14 1990-01-08
JP2679745B2 (ja) * 1989-06-29 1997-11-19 明治製菓株式会社 アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
JPH0347053U (en:Method) * 1989-09-16 1991-04-30
FI964909A7 (fi) * 1994-06-10 1996-12-09 Altana Pharma Ag Substituoidut aryylialkyylitioalkyylipyridiinit Helicobacter-bakteerie n torjumiseksi
CN1636564A (zh) * 1999-08-26 2005-07-13 艾伊法马公司 含烷氧基取代苯并咪唑化合物的组合物和药物制剂及其制法
IL163625A0 (en) * 2002-03-27 2005-12-18 Altana Pharma Ag Alkoxy-pyridine derivatives and pharmaceutical compositions containing the same
WO2004076451A1 (en) 2003-02-25 2004-09-10 Altana Pharma Ag Imidazo[4,5-b]quinoline-derivatives and their use as no-synthase inhibitors
AU2004276015A1 (en) * 2003-10-01 2005-04-07 Altana Pharma Ag Imidazopyridine-derivatives as inductible no-synthase inhibitors
US20080125460A1 (en) * 2003-10-01 2008-05-29 Altana Pharma Ag Imidazopyridine-Derivatives As Inducible No-Synthase Inhibitors
CN100422182C (zh) 2003-10-01 2008-10-01 奥坦纳医药公司 作为诱导型no-合酶抑制剂的咪唑并吡啶类衍生物
CN100415746C (zh) 2003-10-01 2008-09-03 奥坦纳医药公司 氨基吡啶衍生物作为可诱导的no-合酶抑制剂
RS20060205A (en) * 2003-10-01 2008-08-07 Altana Pharma Ag., Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors
WO2007105551A1 (ja) * 2006-03-10 2007-09-20 Arigen Pharmaceuticals, Inc. 抗ヘリコバクター・ピロリ作用を有する新規ピリジン誘導体
EP2070923A1 (de) 2007-12-11 2009-06-17 Bayer CropScience AG Insektizide Iminoheterocyclen
CN103038229B (zh) * 2010-05-26 2016-05-11 桑诺维恩药品公司 杂芳基化合物及其使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (en:Method) * 1968-10-21 1971-06-03

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248880A (en) 1977-09-19 1981-02-03 Hoffmann-La Roche Inc. Treatment of gastric ulcers with naphthimidazole derivatives
US4182766A (en) * 1977-09-19 1980-01-08 Hoffmann-La Roche Inc. Naphth[2,3-d]imidazoles
US4746667A (en) * 1981-08-13 1988-05-24 Aktiebolaget Hassle Pharmaceutical composition containing 2-(2-benzimidazolyl thiomethyl) pyridine
GB2134523A (en) * 1983-02-11 1984-08-15 Haessle Ab Novel pharmacologically active compounds
AU578891B2 (en) * 1983-02-11 1988-11-10 Aktiebolaget Hassle Substituted 2-pyridylobenzimidazole derivatives
EP0150586B1 (en) * 1983-12-05 1991-05-08 The Upjohn Company 2-(pyridylmethylthio)benzimidazoles and 2-(pyridylmethylsulfinyl)benzimidazoles
EP0233284B1 (en) * 1985-10-29 1992-08-19 Aktiebolaget Hässle Pharmacological compounds
LT3810B (en) 1986-11-21 1996-03-25 Haessle Ab New benzimidazole derivatives, a process for production thereof and a pharmaceuticalcomposition containing the same
EP0510719A1 (en) 1986-11-21 1992-10-28 Aktiebolaget Hässle Benzimidazole derivatives substituted with a radical group and their use for inhibiting gastric acid secretion
US5175286A (en) * 1988-09-20 1992-12-29 Hisamitsu Pharmaceutical Co., Inc. Dibenz[b,e]oxepin derivatives
LT3914B (en) 1988-12-22 1996-04-25 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
LT3980B (en) 1988-12-22 1996-06-25 Haessle Ab New therapeutically active compound and a process for its preparation
US5008278A (en) * 1988-12-22 1991-04-16 Aktiebolaget Hassle Therapeutically active compound and a process for its preparation
LT3981B (en) 1988-12-22 1996-06-25 Haessle Ab Therapeutically active substituted benzimidazole and process for its preparation
US5025024A (en) * 1988-12-22 1991-06-18 Aktiebolaget Hassle Therapeutically active fluoro-substituted compound
LT3809B (en) 1989-12-20 1996-03-25 Haessle Ab Therapeutically active fluoro substituted benzimidazoles, process for their preparation as well as their use
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5441968A (en) * 1989-12-20 1995-08-15 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
LT3952B (en) 1990-06-20 1996-05-27 Astra Ab Substituted benzimidazoles, process for their preparation and their pharmaceutical use
LT3977B (en) 1990-06-20 1996-06-25 Astra Ab Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use

Also Published As

Publication number Publication date
IE40858B1 (en) 1979-08-29
FI59590C (fi) 1981-09-10
JPS5924157B2 (ja) 1984-06-07
LU71872A1 (en:Method) 1975-12-09
BE825655A (fr) 1975-08-18
HK67080A (en) 1980-12-05
AT343659B (de) 1978-06-12
MY8100208A (en) 1981-12-31
CA1060448A (en) 1979-08-14
FI750421A7 (en:Method) 1975-08-19
DE2504252A1 (de) 1975-08-21
DE2504252C2 (en:Method) 1989-02-02
NL7501917A (nl) 1975-08-20
AU7820675A (en) 1976-08-19
FI59590B (fi) 1981-05-29
DK141122B (da) 1980-01-21
FR2261007A1 (en:Method) 1975-09-12
IE40858L (en) 1975-08-18
SE7402101L (en:Method) 1975-08-19
SE418966B (sv) 1981-07-06
AU499639B2 (en) 1979-04-26
ZA75558B (en) 1976-01-28
SU795476A3 (ru) 1981-01-07
DD119422A5 (en:Method) 1976-04-20
CS194715B2 (en) 1979-12-31
CH616160A5 (en) 1980-03-14
DK54075A (en:Method) 1975-10-20
DK141122C (en:Method) 1980-07-07
JPS50116474A (en) 1975-09-11
HU172141B (hu) 1978-06-28
ATA113775A (de) 1977-10-15
NO142401C (no) 1980-08-13
NO142401B (no) 1980-05-05
NO750541L (en:Method) 1975-08-19
FR2261007B1 (en:Method) 1978-11-24

Similar Documents

Publication Publication Date Title
GB1500043A (en) Benzimidazole derivatives their preparation and their use in affecting gastric acid secretion
ATE108763T1 (de) Neue benzocyclohepten-derivate, deren herstellung und verwendung für pharmazeutika.
HUT45236A (en) Process for producing new benzimidazole derivatives
SE8002292L (sv) 4-amino-3-kinolinkarboxylsyror och estrar som antisekretoriska anti-ulcerosa foreningar
AU554227B2 (en) Vicinal dihydroxyalkylxanthine derivatives
FR2355796A1 (fr) Procede de preparation de fluorures d'acides perfluoro-alcoxy-propioniques
ES8802137A1 (es) Un precedimiento para preparar derivados de ciclopentil-eter
ATE39920T1 (de) Cyclopentylether, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung.
ES8100284A1 (es) Un procedimiento de preparacion de derivados del jurano
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
ES483087A1 (es) Procedimiento para la obtencion de bencimidazolcarbamatos
ES427869A1 (es) Procedimiento para la preparacion de esteres alcoholicos deacido 5-fenilsulfinil-2-bencimidazol-carbamico.
GB1504589A (en) Substituted cephalosporin antibiotics
DE3264007D1 (en) 5,6-dihydro-11-alkylene-morphantridin-6-ones, process for their preparation and pharmaceutical preparations containing them
SE7806445L (sv) Alkanolaminderivat och sett for deras framstellning
FR2434142A1 (fr) Procede de preparation d'amino-hydroxyanthraquinones
ES387349A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-ami-nopropanos racemicos u opticamente activos.
ES8101601A1 (es) Un procedimiento para la preparacion de una penicilina
ES291803A1 (es) Procedimiento de fabricaciën del beta-(neftil) -1) beta'tetrahidrofuril isobutirato de n-dietilaminoetilo
EP0091057A3 (en) 5,6-dihydro-11-alkylene-mophantridin-6-ones, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee